Systemic MIF facilitates chronic lymphocytic leukemia development independent of its cellular source

Viktoria Kohlhas(Düsseldorf University Hospital), Michael Hallek(Integrated Oncology (United States))

Journal of Leukocyte Biology

November 28, 2025

10.1093/jleuko/qiaf170

Cited by 0

Related Papers

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines

|Blood|2008|3.2k

iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL

|Blood|2018|1.7k

Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia

|New England Journal of Medicine|2014|1.7k

Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

|Annals of Oncology|2015|604

Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

|Annals of Oncology|2020|568